David A. Ramsay
EVP, PRESIDENT, DRUG DELIVERY · HALOZYME THERAPEUTICS, INC.
- 2024
- Jul 2, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David A. Ramsay files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
- Matthew L. Posard - $2.61M in HALO purchases and sales in the last 12 months
- David L. Lowrance - $2.24M in SVRA purchases and sales in the last 12 months
- Cortney Caudill - $1.96M in HALO purchases and sales in the last 12 months
- Bernadette Connaughton - $699K in HALO purchases and sales in the last 12 months
- Mahesh Krishnan - $548K in HALO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David A. Ramsay?
David A. Ramsay is a corporate insider, tracked as EVP, PRESIDENT, DRUG DELIVERY of HALOZYME THERAPEUTICS, INC. (HALO). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did David A. Ramsay last file a Form 4?
The most recent primary Form 4 on record is dated 2 July 2026, one of 7 filings going back to 2024.
Has David A. Ramsay been buying or selling stock?
Recorded transactions: 2 open-market purchases ($704K) and 1 open-market sale ($121K) across all tracked filings.
